-
1
-
-
0032923932
-
CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome?
-
Murray CK, Estey E, Paietta E, et al. CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? J Clin Oncol. 1999;17(1):293-297.
-
(1999)
J Clin Oncol
, vol.17
, Issue.1
, pp. 293-297
-
-
Murray, C.K.1
Estey, E.2
Paietta, E.3
-
2
-
-
0034061846
-
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
-
Ferrara F, Morabito F, Martino B, et al. CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. J Clin Oncol. 2000;18(6):1295-1300. (Pubitemid 30159848)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.6
, pp. 1295-1300
-
-
Ferrara, F.1
Morabito, F.2
Martino, B.3
Specchia, G.4
Liso, V.5
Nobile, F.6
Boccuni, P.7
Di, N.R.8
Pane, F.9
Annunziata, M.10
Schiavone, E.M.11
De, S.M.12
Guglielmi, C.13
Del, V.L.14
Lo, C.F.15
-
3
-
-
3242891691
-
Clinical and biological significance of CD56 antigen expression in acute promyelocytic leukemia
-
DOI 10.1080/10428190410001683624
-
Ito S, Ishida Y, Oyake T, Satoh M, et al. Clinical and biological significance of CD56 antigen expression in acute promyelocytic leukemia. Leuk Lymphoma. 2004;45(9):1783-1789. (Pubitemid 38997144)
-
(2004)
Leukemia and Lymphoma
, vol.45
, Issue.9
, pp. 1783-1789
-
-
Ito, S.1
Ishida, Y.2
Oyake, T.3
Satoh, M.4
Aoki, Y.5
Kowata, S.6
Uchiyama, T.7
Enomoto, S.8
Sugawara, T.9
Numaoka, H.10
Suzuki, K.11
Murai, K.12
-
4
-
-
33645387266
-
The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes
-
Albano F, Mestice A, Pannunzio A, et al. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. Haematologica. 2006;91(3):311-316.
-
(2006)
Haematologica
, vol.91
, Issue.3
, pp. 311-316
-
-
Albano, F.1
Mestice, A.2
Pannunzio, A.3
-
5
-
-
2342541801
-
A Surrogate Marker Profile for PML/RARalpha Expressing Acute Promyelocytic Leukemia and the Association of Immunophenotypic Markers with Morphologic and Molecular Subtypes
-
Paietta E, Goloubeva O, Neuberg D, et al.Asurrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Cytometry B Clin Cytom. 2004;59(1):1-9. (Pubitemid 38581544)
-
(2004)
Cytometry Part B - Clinical Cytometry
, vol.59
, Issue.1
, pp. 1-9
-
-
Paietta, E.1
Goloubeva, O.2
Neuberg, D.3
Bennett, J.M.4
Gallagher, R.5
Racevskis, J.6
Dewald, G.7
Wiernik, P.H.8
Tallman, M.S.9
-
6
-
-
10744220024
-
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: A multicenter study by the PETHEMA group
-
DOI 10.1182/blood-2003-07-2462
-
Sanz MA, Martin G, Gonzalez M, et al. Riskadapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood. 2004;103(4):1237-1243. (Pubitemid 38168633)
-
(2004)
Blood
, vol.103
, Issue.4
, pp. 1237-1243
-
-
Sanz, M.A.1
Martin, G.2
Gonzalez, M.3
Leon, A.4
Rayon, C.5
Rivas, C.6
Colomer, D.7
Amutio, E.8
Capote, F.J.9
Milone, G.A.10
De, L.S.J.11
Roman, J.12
Barragan, E.13
Bergua, J.14
Escoda, L.15
Parody, R.16
Negri, S.17
Calasanz, M.J.18
Bolufer, P.19
-
7
-
-
77954681398
-
Riskadapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome
-
Sanz MA, Montesinos P, Rayon C, et al. Riskadapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood. 2010;115(25):5137-5146.
-
(2010)
Blood
, vol.115
, Issue.25
, pp. 5137-5146
-
-
Sanz, M.A.1
Montesinos, P.2
Rayon, C.3
-
8
-
-
0028837561
-
Proposals for the immunological classification of acute leukemias
-
European Group for the Immunological Characterization of Leukemias (EGIL)
-
Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9(10):1783-1786.
-
(1995)
Leukemia
, vol.9
, Issue.10
, pp. 1783-1786
-
-
Bene, M.C.1
Castoldi, G.2
Knapp, W.3
-
9
-
-
0344336086
-
Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases
-
DOI 10.1046/j.1365-2141.1998.00871.x
-
Guglielmi C, Martelli MP, Diverio D, et al. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol. 1998;102(4):1035-1041. (Pubitemid 28410536)
-
(1998)
British Journal of Haematology
, vol.102
, Issue.4
, pp. 1035-1041
-
-
Guglielmi, C.1
Martelli, M.P.2
Diverio, D.3
Fenu, S.4
Vegna, M.L.5
Cantu-Rajnoldi, A.6
Biondi, A.7
Cocito, M.G.8
Del, V.L.9
Tabilio, A.10
Avvisati, G.11
Basso, G.12
Lo, C.F.13
-
10
-
-
1542753559
-
Revised Recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
-
DOI 10.1200/JCO.2003.04.036
-
Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003;21(24):4642-4649. (Pubitemid 46594039)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.24
, pp. 4642-4649
-
-
Cheson, B.D.1
Bennett, J.M.2
Kopecky, K.J.3
Buchner, T.4
Willman, C.L.5
Estey, E.H.6
Schiffer, C.A.7
Doehner, H.8
Tallman, M.S.9
Lister, T.A.10
LoCocco, F.11
Willemze, R.12
Biondi, A.13
Hiddemann, W.14
Larson, R.A.15
Lowenberg, B.16
Sanz, M.A.17
Head, D.R.18
Ohno, R.19
Bloomfield, C.D.20
more..
-
11
-
-
17344370602
-
Preliminary experience in external quality control of RT-PCR PML-RARalpha detection in promyelocytic leukemia
-
Bolufer P, Barragan E, Sanz MA, et al. Preliminary experience in external quality control of RT-PCR PML-RAR alpha detection in promyelocytic leukemia. Leukemia. 1998;12(12):2024-2028. (Pubitemid 28554475)
-
(1998)
Leukemia
, vol.12
, Issue.12
, pp. 2024-2028
-
-
Bolufer, P.1
Barragan, E.2
Sanz, M.A.3
Martin, G.4
Bornstein, R.5
Colomer, D.6
Delgado, M.D.7
Gonzalez, M.8
Marugan, I.9
Roman, J.10
Gomez, M.T.11
Anguita, E.12
Diverio, D.13
Chomienne, Ch.14
Briz, M.15
-
12
-
-
59649106888
-
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: Characteristics, outcome, and prognostic factors
-
Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009;113(4):775-783.
-
(2009)
Blood
, vol.113
, Issue.4
, pp. 775-783
-
-
Montesinos, P.1
Bergua, J.M.2
Vellenga, E.3
-
13
-
-
77949733334
-
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
-
Cervera J, Montesinos P, Hernández-Rivas JM, et al. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Haematologica. 2010;95(3):424-431.
-
(2010)
Haematologica
, vol.95
, Issue.3
, pp. 424-431
-
-
Cervera, J.1
Montesinos, P.2
Hernández-Rivas, J.M.3
-
14
-
-
0034663162
-
Definition of relapse risk and role of nonanthracycline drags for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups
-
Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96(4):1247-1253. (Pubitemid 30658450)
-
(2000)
Blood
, vol.96
, Issue.4
, pp. 1247-1253
-
-
Sanz, M.A.1
Lo, C.F.2
Martin, G.3
Avvisati, G.4
Rayon, C.5
Barbui, T.6
Diaz-Mediavilla, J.7
Fioritoni, G.8
Gonzalez, J.D.9
Liso, V.10
Esteve, J.11
Ferrara, F.12
Bolufer, P.13
Bernasconi, C.14
Gonzalez, M.15
Rodeghiero, F.16
Colomer, D.17
Petti, M.C.18
Ribera, J.M.19
Mandelli, F.20
more..
-
15
-
-
33845382806
-
Nonparametric estimations from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
16
-
-
0013886333
-
Evaluation of survival data and two new rank order statistics arising in its consideration
-
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163-170.
-
(1966)
Cancer Chemother Rep
, vol.50
, Issue.3
, pp. 163-170
-
-
Mantel, N.1
-
17
-
-
0000120995
-
A class of K-sample test for comparing the cumulative incidence of a competing risk
-
Gray RJ. A class of K-sample test for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141-1154.
-
(1988)
Ann Stat
, vol.16
, Issue.3
, pp. 1141-1154
-
-
Gray, R.J.1
-
18
-
-
0027166881
-
Kaplan-Meier, marginal or conditional probability curves in summarizing competing risk failure time data?
-
Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risk failure time data? Stat Med. 1993;12(8):737-751.
-
(1993)
Stat Med
, vol.12
, Issue.8
, pp. 737-751
-
-
Pepe, M.S.1
Mori, M.2
-
19
-
-
0000336139
-
Regression models and life tables
-
with discussion
-
Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187-220.
-
(1972)
J R Stat Soc B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
20
-
-
1542532754
-
A proportional hazards model for the subdistribution of a competing risk
-
Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Fine, J.1
Gray, R.2
-
22
-
-
33751167022
-
Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: Implications for the cellular target of t(15;17)
-
Chapiro E, Delabesse E, Asnafi V, et al. Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17). Blood. 2006;108(10):3484-3493.
-
(2006)
Blood
, vol.108
, Issue.10
, pp. 3484-3493
-
-
Chapiro, E.1
Delabesse, E.2
Asnafi, V.3
-
23
-
-
43549105926
-
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
-
de la Serna J, Montesinos P, Vellenga E, et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008;111(7):3395-3402.
-
(2008)
Blood
, vol.111
, Issue.7
, pp. 3395-3402
-
-
De La Serna, J.1
Montesinos, P.2
Vellenga, E.3
-
24
-
-
17944381145
-
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis
-
DOI 10.1038/sj.leu.2402174
-
Raspadori D, Damiani D, Lenoci M, et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia. 2001;15(8):1161-1164. (Pubitemid 32776438)
-
(2001)
Leukemia
, vol.15
, Issue.8
, pp. 1161-1164
-
-
Raspadori, D.1
Damiani, D.2
Lenoci, M.3
Rondelli, D.4
Testoni, N.5
Nardi, G.6
Sestigiani, C.7
Mariotti, C.8
Birtolo, S.9
Tozzi, M.10
Lauria, F.11
-
25
-
-
73949119197
-
CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications
-
Xu N, Liu XL, DU QF, et al. CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29(8):1605-1608.
-
(2009)
Nan Fang Yi Ke Da Xue Xue Bao
, vol.29
, Issue.8
, pp. 1605-1608
-
-
Xu, N.1
Liu, X.L.2
Qf, D.U.3
-
26
-
-
76449088952
-
Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity
-
Ando T, Mitani N, Matsui K, et al. Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity. Int J Hematol. 2009;90(3):374-377.
-
(2009)
Int J Hematol
, vol.90
, Issue.3
, pp. 374-377
-
-
Ando, T.1
Mitani, N.2
Matsui, K.3
-
27
-
-
3843063490
-
Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome
-
DOI 10.1016/j.leukres.2004.01.006, PII S0145212604000372
-
Chang H, Brandwein J, Yi QL, et al. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res. 2004;28(10):1007-1011. (Pubitemid 39037332)
-
(2004)
Leukemia Research
, vol.28
, Issue.10
, pp. 1007-1011
-
-
Chang, H.1
Brandwein, J.2
Yi, Q.-L.3
Chun, K.4
Patterson, B.5
Brien, B.6
-
28
-
-
0030838704
-
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21) (q22;q22)
-
Baer MR, Stewart CC, Lawrence D, et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22; q22). Blood. 1997;90(4):1643-1648. (Pubitemid 27355438)
-
(1997)
Blood
, vol.90
, Issue.4
, pp. 1643-1648
-
-
Baer, M.R.1
Stewart, C.C.2
Lawrence, D.3
Arthur, D.C.4
Byrd, J.C.5
Davey, F.R.6
Schiffer, C.A.7
Bloomfield, C.D.8
-
29
-
-
3843139439
-
Extramedullay acute myeloid leukemia infiltrates
-
DOI 10.1016/j.leukres.2004.03.021, PII S0145212604001808
-
Tallman MS. Extramedullary acute myeloid leukemia infiltrates. Leuk Res. 2004;28(10):1005-1006. (Pubitemid 39037331)
-
(2004)
Leukemia Research
, vol.28
, Issue.10
, pp. 1005-1006
-
-
Tallman, M.S.1
|